LCN2 and diabetic kidney disease: It mediates signaling through the epidermal growth factor receptor, which in turn activates hypoxia-inducible factor 1-alpha, ultimately promoting cell proliferation, cytogenesis, renal injury, and the progression of DKD, suggesting that NGAL may represent a surrogate index of renal function decline in DKD [9].